国产福利酱国产一区二区|亚洲精品一区二区三区成人|9l肥熟女福利视频导航|91嫩草国产线永久在线观看|免费99在线视频播放|明明成人免费高清在线观看

更新于 5月21日

BAS-中心試驗(yàn)室檢驗(yàn)科專(zhuān)家

2-3萬(wàn)
  • 上海浦東新區(qū)
  • 經(jīng)驗(yàn)不限
  • 本科
  • 全職
  • 招1人

雇員點(diǎn)評(píng)標(biāo)簽

  • 工作環(huán)境好
  • 同事很nice
  • 團(tuán)隊(duì)執(zhí)行強(qiáng)
  • 氛圍活躍
  • 人際關(guān)系好
  • 免費(fèi)班車(chē)
  • 交通便利
  • 非常鍛煉人

職位描述

分析
崗位職責(zé):
1.Be responsible for the technical and scientific oversight of the laboratory·
2.Manage and supervise laboratory tests following for safety lab testing, including but not limited to hematology, chemistry, urinalysis, coagulation, microbiology, immunology, flow cytometry, etc..
3.Create/update SOP following the CAP, CLIA, GLP regulations.
4.Oversee the quality of central lab performances.
5.Project management of clinical trials in central laboratory.
6.Work with company project manager or BD person to bid on projects.
7.Participate in TC with clients for any lab related issues.
8.Talent training and retention
9.Other tasks assigned by Dept. leader.
任職要求:
1.At least bachelor
s degree or above in a medical technology, medical technology from an accredited institution. Licensed to practice in a medical/safety/pathology laboratory, with at least intermediate-level professional certificate. MD or DO in medical testing field is preferred.
2.Strong background in validating or transferring clinical tests.
3.At least 8 years of working experience in CRO industry and CAP or CLIA accredited Laboratory, with rich experience in coagulation testing and microscopic examination in hemanalysis and urinalysis testing.
4.Fluent in both English and Chinese.

工作地點(diǎn)

浦東新區(qū)中國(guó)上海外高橋自貿(mào)區(qū)富特中路288號(hào)

職位發(fā)布者

劉先生/資深人力資源

三日內(nèi)活躍
立即溝通
公司Logo藥明康德新藥開(kāi)發(fā)有限公司
藥明康德(股票代碼:603259.SH/2359.HK)為全球醫(yī)藥及生命科學(xué)行業(yè)提供一體化、端到端的新藥研發(fā)和生產(chǎn)服務(wù),在亞洲、歐洲、北美等地均設(shè)有運(yùn)營(yíng)基地。藥明康德通過(guò)獨(dú)特的“CRDMO”業(yè)務(wù)模式,不斷降低研發(fā)門(mén)檻,助力客戶(hù)提升研發(fā)效率,為患者帶來(lái)更多突破性的治療方案,服務(wù)范圍涵蓋化學(xué)藥研發(fā)和生產(chǎn)、生物學(xué)研究、臨床前測(cè)試和臨床試驗(yàn)研究等領(lǐng)域。2024年,藥明康德連續(xù)第四年被MSCI評(píng)為ESG(環(huán)境、社會(huì)及管治)AA級(jí)。目前,公司的賦能平臺(tái)正承載著來(lái)自全球30多個(gè)國(guó)家約6,000家合作伙伴的研發(fā)創(chuàng)新項(xiàng)目,致力于將更多新藥、好藥帶給全球病患,早日實(shí)現(xiàn)“讓天下沒(méi)有難做的藥,難治的病”的愿景。
公司主頁(yè)